Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, development, and production of genetic engineering and related drugs People’s Republ...
Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%
National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance
SL PHARM: GLP-1 long-acting products are organizing materials in preparation for reporting
SL PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 141 million yuan, a year-on-year increase of 943.10%
SL PHARM: The invested company Changfeng Pharmaceutical plans to go public in Hong Kong on October 8
SL PHARM: Liang Shujie plans to reduce her holdings by 0.0365%